10,491 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Acquired by Allstate Corp

Allstate Corp purchased a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 10,491 shares of the medical equipment provider's stock, valued at approximately $5,476,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Brown Brothers Harriman & Co. raised its holdings in Intuitive Surgical by 26.9% during the fourth quarter. Brown Brothers Harriman & Co. now owns 3,373 shares of the medical equipment provider's stock valued at $1,761,000 after buying an additional 714 shares in the last quarter. DnB Asset Management AS raised its stake in shares of Intuitive Surgical by 8.0% in the fourth quarter. DnB Asset Management AS now owns 100,531 shares of the medical equipment provider's stock valued at $52,473,000 after purchasing an additional 7,406 shares in the last quarter. Alerus Financial NA lifted its holdings in shares of Intuitive Surgical by 177.1% during the 4th quarter. Alerus Financial NA now owns 9,678 shares of the medical equipment provider's stock worth $5,052,000 after acquiring an additional 6,186 shares during the period. Level Four Advisory Services LLC grew its stake in shares of Intuitive Surgical by 18.3% in the 4th quarter. Level Four Advisory Services LLC now owns 894 shares of the medical equipment provider's stock valued at $467,000 after purchasing an additional 138 shares during the period. Finally, Vertex Planning Partners LLC raised its stake in Intuitive Surgical by 3.7% during the fourth quarter. Vertex Planning Partners LLC now owns 851 shares of the medical equipment provider's stock worth $444,000 after acquiring an additional 30 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Remove Ads

Analysts Set New Price Targets

Several brokerages have recently commented on ISRG. JPMorgan Chase & Co. increased their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an "overweight" rating in a report on Friday, January 24th. Evercore ISI increased their target price on shares of Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Barclays raised their target price on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Citigroup increased their price objective on shares of Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. Finally, Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and boosted their price objective for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. One analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $611.86.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $0.84 on Tuesday, hitting $496.11. 1,241,258 shares of the stock were exchanged, compared to its average volume of 1,530,393. The company has a market capitalization of $176.70 billion, a PE ratio of 77.40, a P/E/G ratio of 5.85 and a beta of 1.43. The business's fifty day moving average is $554.33 and its 200 day moving average is $532.98. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Activity

In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the company's stock in a transaction that occurred on Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares in the company, valued at $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Robert Desantis sold 11,545 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares of the company's stock, valued at $2,607,925.28. This represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.